 |
answer text |
<p>NHS England has been asked to provide an interim report to the Secretary of State
for Health and Social Care by the end of May 2019. The review will be clinically led
by the NHS England and NHS Improvement Medical Director and Chief Pharmaceutical Officer,
drawing on further specialist support as required.</p><p>NHS England will work with
patient groups and the All Party Parliamentary Group on Medical Cannabis under Prescription
to identify a sample of patients that have been seeking to access cannabis-based products
for medicinal use through the National Health Service. Case reviews will involve interviews
with relevant individuals who are involved in the decision to prescribe cannabis-based
products for medicinal use, including patients, carers and relevant trust staff.</p>
|
 |
